| Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation C Puppin, C Durante, M Sponziello, A Verrienti, V Pecce, E Lavarone, ... Endocrine 47, 528-536, 2014 | 51 | 2014 |
| The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells L Allegri, F Baldan, S Roy, J Aubé, D Russo, S Filetti, G Damante Scientific reports 9 (1), 7374, 2019 | 48 | 2019 |
| Effects of nutraceuticals on anaplastic thyroid cancer cells L Allegri, F Rosignolo, C Mio, S Filetti, F Baldan, G Damante Journal of cancer research and clinical oncology 144, 285-294, 2018 | 48 | 2018 |
| MCM5 as a target of BET inhibitors in thyroid cancer cells C Mio, E Lavarone, K Conzatti, F Baldan, B Toffoletto, C Puppin, S Filetti, ... Endocrine-related cancer 23 (4), 335-347, 2016 | 46 | 2016 |
| Anti-hTERT siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer Xenograft GE Lombardo, V Maggisano, M Celano, D Cosco, C Mignogna, F Baldan, ... Molecular Cancer Therapeutics 17 (6), 1187-1195, 2018 | 44 | 2018 |
| Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells V Maggisano, M Celano, GE Lombardo, SM Lepore, M Sponziello, ... Molecular and cellular endocrinology 448, 34-40, 2017 | 44 | 2017 |
| Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer‐Derived Cell Line F Baldan, C Mio, L Allegri, C Puppin, D Russo, S Filetti, G Damante International journal of endocrinology 2015 (1), 978371, 2015 | 36 | 2015 |
| Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells F Baldan, C Mio, L Allegri, K Conzatti, B Toffoletto, C Puppin, S Radovic, ... Oncotarget 7 (39), 63388, 2016 | 26 | 2016 |
| Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells L Allegri, F Baldan, C Mio, C Puppin, D Russo, V KRYšTOF, G Damante Oncology Reports 35 (4), 2413-2418, 2016 | 24 | 2016 |
| Biological and molecular effects of bromodomain and extra‐terminal (BET) inhibitors JQ 1, IBET‐151, and IBET‐762 in OSCC cells F Baldan, L Allegri, M Lazarevic, C Mio, M Milosevic, G Damante, ... Journal of Oral Pathology & Medicine 48 (3), 214-221, 2019 | 23 | 2019 |
| Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma F Rosignolo, M Sponziello, C Durante, C Puppin, C Mio, F Baldan, ... PLoS One 11 (6), e0156658, 2016 | 23 | 2016 |
| A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis P Dello Russo, A Franzoni, F Baldan, C Puppin, G De Maglio, C Pittini, ... BMC Medical Genetics 16, 1-6, 2015 | 21 | 2015 |
| Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells F Baldan, C Mio, E Lavarone, C Di Loreto, F Puglisi, G Damante, ... Oncology Reports 33 (5), 2199-2206, 2015 | 21 | 2015 |
| Effects of HuR downregulation on anaplastic thyroid cancer cells L Allegri, C Mio, D Russo, S Filetti, F Baldan Oncology Letters 15 (1), 575-579, 2018 | 19 | 2018 |
| NK2 homeobox gene cluster: Functions and roles in human diseases C Mio, F Baldan, G Damante Genes & Diseases 10 (5), 2038-2048, 2023 | 16 | 2023 |
| Genomic deletion involving the IMMP2L gene in two cases of autism spectrum disorder F Baldan, C Gnan, A Franzoni, L Ferino, L Allegri, N Passon, G Damante Cytogenetic and Genome Research 154 (4), 196-200, 2018 | 15 | 2018 |
| BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome L Allegri, F Baldan, C Mio, M De Felice, E Amendola, G Damante European journal of medical genetics 63 (6), 103894, 2020 | 14 | 2020 |
| Cationic carboxylate and thioacetate ruthenium (II) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells D Lovison, L Allegri, F Baldan, M Ballico, G Damante, C Jandl, W Baratta Dalton Transactions 49 (24), 8375-8388, 2020 | 14 | 2020 |
| BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells C Mio, K Conzatti, F Baldan, L Allegri, M Sponziello, F Rosignolo, ... Oncology reports 39 (2), 582-588, 2018 | 14 | 2018 |
| Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium (II) Complexes Against Cancer Cells D Lovison, D Alessi, L Allegri, F Baldan, M Ballico, G Damante, M Galasso, ... Chemistry–A European Journal 28 (33), e202200200, 2022 | 12 | 2022 |